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Brief Communications
Injections of Intravenous Contrast for Computerized
Tomography Scans Precipitate Migraines in Hereditary
Hemorrhagic Telangiectasia Subjects at Risk of Paradoxical
Emboli: Implications for Right-to-Left Shunt Risks
Trishan Patel, BSc; Amy Elphick, BSc; James E. Jackson, FRCP FRCR; Claire L. Shovlin, PhD FRCP
Objective.—To evaluate if injection of intravenous particles may provoke migraines in subjects with right-to-left
shunts due to pulmonary arteriovenous malformations (AVMs).
Background.—Migraine headaches commonly affect people with hereditary hemorrhagic telangiectasia (HHT), espe-
cially those with pulmonary AVMs that provide right-to-left shunts. In our clinical practice, patients occasionally reported
acute precipitation of migraine headaches following injection of technetium-labeled albumin macroaggregates for nuclear
medicine scans.
Methods.—Self-reported migraine features and exacerbations were examined in HHT subjects with and without pul-
monary AVMs, for a series of noninvasive and invasive investigations, using an unbiased online survey.
Results.—One hundred and sixty-six subjects were classified as having both HHT and migraines. HHT subjects with
migraines were more likely to have pulmonary AVMs (P< .0001). HHT subjects with pulmonary AVMs were more likely to
report photophobia (P5 .010), “flashes of light” (P5 .011), or transient visual loss (P5 .040). Pulse oximetry, x-rays, ultra-
sound, and computerized tomography (CT) scans without intravenous contrast medium rarely, if ever, provoked migraines,
but unenhanced magnetic resonance imaging (MRI) was reported to exacerbate migraines by 14/124 (11.2%) subjects. One
hundred and fourteen subjects had both enhanced and unenhanced CT examinations: studies with contrast media were more
commonly reported to start (9/114 [7.8%]), and/or worsen migraines (18/114 [15.7%]), compared to those undertaken without
contrast medium (P< .01), or after simple blood tests (P< .05). Additionally, migraine exacerbation was reported by 9/90
(10%) after contrast echocardiography, 2/44 (4.5%) after nuclear medicine scans, and 10/154 (6.5%) after blood tests.
Conclusions.—HHT subjects frequently report migraine exacerbation following blood tests, contrast echocardiograms,
MRI imaging, and CT studies performed with intravenous contrast medium. Since air emboli are recognized to complicate
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intravenous injections, particularly those given by a pressurized pump during contrast enhanced CT, future studies should
re-evaluate whether particulate emboli provoke migraines.
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INTRODUCTION
Observations in a group of patients who have
continuous right-to-left (R-L) shunts led us to
hypothesize that particulate paradoxical emboli
may provoke migraines: Pulmonary arteriovenous
malformations (AVMs) are abnormal vessels that
allow blood to bypass the pulmonary capillary bed.1
Patients are at high risk of paradoxical embolic
strokes2 and migraines,3 with risks reduced by pul-
monary AVM treatment.1–3 Macroscopic pulmo-
nary AVMs affect approximately 50% of people
with the inherited vascular disorder, hereditary
hemorrhagic telangiectasia (HHT).1 HHT patients
also exhibit intrapulmonary R-L shunting in the
absence of overt pulmonary AVMs visible by com-
puterized tomography (CT) scans or angiography.1,4
Intrapulmonary R-L shunts are considered part of
the reason why HHT patients have a higher preva-
lence of migraines than the general population.3,5,6
In our clinical practice, patients occasionally
reported acute precipitation of migraine headaches
following R-L shunt measurements by nuclear medi-
cine scans involving the injection of 99mtechnetium-
labeled albumin macroaggregates (10–80 lm diame-
ter).2 This led us to hypothesize that injection of intra-
venous particles in diagnostic studies may provoke
migraines in HHT patients with pulmonary AVMs.
METHODS
Relevant questions were designed for inclusion
in a wider HHT survey that did not specify specific
study aims. The NRES Committee East Midlands-
Derby 1 Research Ethics Committee approved the
study, which recruited between August 2013 and
April 2015. The survey invitation was distributed by
post using the Imperial College London HHTIC
London Clinical Service databases (2012 to 2014);
during attendance at the HHT clinics; and advertised
by the HHT Foundation International, and HHT
UK. The basic study design has been reported previ-
ously: each participant provided a single response.5
Briefly, online informed consent was obtained from
all participants who were then asked to provide
demographics, information on their HHT phenotype,
and whether they had any of a number of common
medical conditions, including migraine.
Participants stating that they had migraines
were directed to a set of questions to distinguish
between migrainous and non-migrainous headaches.
Relevant discerning questions were derived from
standardized questions,7 and shrouded with dummy
questions to reduce bias (see Supporting Informa-
tion Data Supplement). Participants were also
asked if something else happened before, during, or
after the headache, and if they ticked “yes,” were
directed to a series of options with tick boxes to indi-
cate if occurrence was never; occasional; with some
migraines; often; with most, or with all migraines.
Participants reporting that they had received particu-
lar investigations were directed to “We would like to
know if having [. . .investigation. . ..] seemed to make
a difference to your migraines” with tick box options
for “I have not had one”; “no different really”;
“seemed a bit better”; “seemed a bit worse” “seemed
to bring on a migraine” “seemed to stop a migraine”
(see Supporting Information Data Supplement).
DATA ANALYSIS
Following preliminary analyses, data were
downloaded from SurveyMonkey in December
2015 and transferred to numeric format using
Microsoft Excel “replace” commands. NewConflict of Interest: The authors report no conflict of interest.
1660 November/December 2016
variables for HHT and migraine diagnoses were
generated, and populated automatically according
to the numeric data within the specific questions:
Blinded to migraine reports, an HHT phenotype
was assigned if at least four features were reported
from nosebleeds at least once per year; telangiecta-
sia (“red spots”) on the lips or finger pads; a stated
family history of HHT; and any reported visceral
AVMs, or if three features included visceral
AVMs. Self-reported migraines were classified as
migraines if there was a formal medical diagnosis
receiving migraine-specified treatments, or, if not
formally diagnosed, if described as a headache of
moderate to severe intensity plus at least three
associated features considered common in migraine
headaches. Additionally, in order to provide a fur-
ther numeric parameter with which to compare
populations, the frequencies of associated features
were assigned to a scale of 0 (never) to 5 (always).
Data were analyzed using STATA IC v12 (Sta-
taCorp, College Station, TX, USA) and GraphPad
Prism (GraphPad Inc, La Jolla, CA, USA). Two
group comparisons were performed using Mann
Whitney or Fisher’s exact test (for proportions).
Multiple groups were compared using Kruskal Wal-
lis with Dunn’s multiple comparison test.
RESULTS
At study closure, 706 individuals had completed
the survey. Five hundred and four survey respondents
met the criteria for diagnosis of HHT and provided
complete datasets for analysis. One hundred and sixty-
six of 504 (32.9%) reported migraines that met medical
diagnosis or severity/association criteria (Table 1). In
the migraine subgroup, ages ranged from 22 to 102
(median 49) years, 139/166 (83.7%) were female, and
41/166 (24.7%) were current or former smokers. HHT
features were generally similar in the groups with and
without migraines, but there was an excess of pulmo-
nary AVMs (P< .0001) and cerebral AVMs
(P5 .0036) in those with migraines (Table 1).
Migraines were typical in type, but not stereotypi-
cal in occurrence (Fig. 1). For example, 105/166
(63.3%) subjects reported nausea/vomiting with at
least some migraines, but only 19/166 (11.5%) reported
nausea/vomiting with all migraines. Subjects with
pulmonary AVMs reported migraines of similar inten-
sity and age progression to the rest of the HHT cohort,
but compared to the other HHT subjects, were more
likely to report a neurological association (P5 .0005);
photophobia (P5 .010); “flashes of light” (P5 .011);
or transient visual loss (P5 .040).
Table 1.—Features of HHT in Subjects With and Without
Migraines
No
migraine
(N5 338)
Migraine
(N5 166)
N % N % P value
Nosebleeds 301 89.1 152 91.6 .38
Daily 182 53.9 72 43.4 .23
Weekly 124 36.7 53 31.9 .38
Monthly 50 14.8 30 18.1 .34
Telangiectasia 309 91.4 144 86.8 .69
Lips 263 77.8 132 79.5 .66
Finger pads 224 66.3 107 64.5 .74
Pulmonary AVMs 142 42.0 108 65.1 .0001
Cerebral AVMs 22 6.5 24 14.5 .0036
Hepatic AVMs 46 13.6 28 16.9 .33
N, number with feature. P values calculated by Mann Whitney.
Fig. 1.—Reported associations with migraine headaches.
Data from the 166 survey respondents meeting diagnostic
criteria for HHT and migraines. The mean score, and stan-
dard error of the mean, are illustrated, noting individual
responses ranged from never (0) to always (5). As reported
elsewhere,5 almost half (70, 43.3%) described sometimes
having an HHT nosebleed at the time of a migraine, and in
14 cases (8.4%) this occurred with most if not all migraines.
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Pulse oximetry, x-rays, ultrasound, and CT
scans without intravenous contrast medium rarely if
ever provoked migraines (Fig. 2).
MRI scans without any injection were reported
to start a migraine by 6/124 (4.8%) subjects, and to
worsen migraines by a further 8/124 (6.5%). MRI
scans “with an injection,” were reported to start a
migraine by 9/110 (8.1%) subjects, and worsen
migraines by a further 12/110 (10.9%). Figure 2
illustrates the subjects reporting any exacerbation
by MRI scans, either without (14/124 [11.2%]), or
with injections (21/110 [19.1%]).
Two of 44 (4.5%) subjects having an albumin
macroaggregate nuclear medicine “shunt” study
reported that the scans started migraines. Similar-
ly, of 90 migraineurs who had a microbubble
contrast-enhanced echocardiography study, nine
(10%) reported migraines were started or made
worse compared to only 2/115 (1.7%) after unen-
hanced echocardiograms (P5 .0091). Similar rates
of migraine provocation (3/154 [2.0%]) and/or
exacerbation (10/154 [6.4%]) were reported after
simple blood tests (Fig. 2).
Differences between contrast enhanced and non-
contrast scans were most pronounced for CT imaging:
For the 114 subjects who described both types of CT
scans, migraine exacerbations were reported by 18/
114 (15.7%) receiving injected iodinated contrast
medium, including 9/114 (7.8%) who stated the scans
started a migraine. Lower proportions reported CT
scans without contrast medium started (2/114 [1.7%])
or started/worsened (4/114 [3.5%]) a migraine (P val-
ues .059 and P< .01, respectively).
DISCUSSION
We have shown in a migraine-prone population
that MRI studies, blood tests, contrast echocardio-
grams, and intravenous injection of iodinated con-
trast medium associated with CT examinations are
reported to provoke or exacerbate migraines.
Migraine headaches were commonly associated
with neurological features, particularly in subjects
with R-L shunts due to pulmonary AVMs.
The main study weaknesses are that it was sur-
vey based (hence bias from study participation, or
participant recall cannot be excluded), and only
modest numbers were recruitable representing the
migraine-affected subgroup of people affected by a
rare medical condition. Direct causality cannot
determined by the study methodology. Additional-
ly, the precise type of intravenous injections that
participants had received was not recorded.
Nevertheless, the actual numbers of subjects for
which data are available is one of the paper’s
strengths, and the findings are provocative. Head-
aches as a result of MRI scans are usually attributed
to noise, but there are emerging concerns regarding
air emboli following intravenous access: It is accept-
ed that air emboli can complicate intravenous injec-
tions (particularly with “pump” injectors for CT-
based contrast), or simple insertion of venous cannu-
lae.8,9 Patients with R-L shunts are at a theoretical
risk of paradoxical embolism of larger microbubbles
before the gas is absorbed, and migraine headaches
do not appear to have been included previously as a
possible clinical outcome.
Fig. 2.—Reported exacerbation of migraines by investiga-
tions. Proportions of subjects reporting investigations exacer-
bated migraines, either starting or worsening a migraine.
White bars: tests without injections, black bars, tests with
injections, and stippled bar, venipuncture for blood tests.
Mean and standard error of the mean displayed. Tests that
never provoked migraines (pulse oximetry, x-rays) are not
displayed. The P values were calculated by Dunn’s multiple
comparison test after performing the Kruskal Wallis test
across all 9 groups (overall P value< .0001).
1662 November/December 2016
We cautiously suggest the findings may be relevant
to wider groups of migraineurs. Migraine features and
precipitants are similar in HHT patients to the general
population.5,7 More than 30% of the general popula-
tion have patent foramen ovale that cause intermittent
R-L shunting (usually only after Valsalva maneuver
reverse pressure differentials between left and right
atria), while 5–8% are considered to have intrapul-
monary R-L shunts at rest, rising on exercise.10
Evaluation of migraines as a potential read-out
for paradoxical emboli is recommended. In the
meantime, for people with HHT and migraines,
pre-test counseling may helpfully include advice to
bring migraine preventers or treatments to help
alleviate any symptoms promptly.
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